MD Anderson launches Institute for Cell Therapy Discovery & Innovation

Korman, Regev, and Rathmell awarded Cancer Research Institute honors in cancer immunotherapy

Alan KormanAviv RegevJeffrey C. RathmellThe Cancer Research Institute has announced the 2025 recipients of the William B. Coley Award for Distinguished Research in Basic and Tumor Immunology and the Frederick W. Alt Award for New Discoveries in Immunology.

October 24, 2025

Vol.51 No.39

Clinical Roundup

Zanzalintinib + atezolizumab improve survival in advanced CRC

Combining zanzalintinib, a targeted therapy drug, and atezolizumab, an immune checkpoint inhibitor, helped patients with metastatic colorectal cancer live longer and control their disease better than with the standard treatment drug regorafenib, according to a study led by UCLA investigators.

October 24, 2025

Vol.51 No.39

Clinical Roundup

Keytruda shows long-term survival benefit in NSCLC

Merck presented long-term data highlighting the sustained survival benefits of Keytruda (pembrolizumab), Merck’s anti-PD-1 therapy, in treating non-small cell lung cancer at the European Society for Medical Oncology Congress 2025.

October 24, 2025

Vol.51 No.39

Clinical Roundup

Keytruda + Padcev reduced risk of EFS events and death for muscle-invasive bladder cancer when given before and after surgery

Keytruda (pembrolizumab) plus Padcev (enfortumab vedotin-ejfv) reduced the risk of event-free survival events by 60% and reduced the risk of death by 50% when given before and after surgery (radical cystectomy) versus surgery alone, the current standard of care, in patients with muscle-invasive bladder cancer who are not eligible for or declined cisplatin-based chemotherapy, according to phase III KEYNOTE-905/EV-303 trial data.

October 24, 2025

Vol.51 No.39

In Brief

CTMC and Einstein Hospital Israelita in Brazil partner to launch the Global Cell Therapy Network Alliance

CTMC, a joint venture between Resilience and MD Anderson Cancer Center, has entered into a collaborative partnership with Einstein Hospital Israelita in Sao Paulo, Brazil, aimed at accelerating the adoption of cell therapy in Brazil and all of Latin America.

October 17, 2025

Vol.51 No.38

Guest Editorial

Championing nurse wellbeing as a strategic priority

Working in a comprehensive cancer center requires emotional endurance, strong clinical judgment, and constant interprofessional collaboration, all of which rest on a foundation of personal wellness. For nurses, whose roles are inherently intensive, focusing on wellbeing is integral to their ability to provide safe, compassionate, and effective patient care.

September 26, 2025

Vol.51 No.35

By Kim Slusser